Paper42536166
Do Current Endpoints Underestimate Benefit in MeVO Stroke? A Call for Cognitive Profiling.
Rus Prelog P and 3 others. Clin Neuroradiol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Do Current Endpoints Underestimate Benefit in MeVO Stroke? A Call for Cognitive Profiling. Papers, record 42536166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42536166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Do Current Endpoints Underestimate Benefit in MeVO Stroke? A Call for Cognitive Profiling.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32486967 | Incidence of Acute Ischemic Stroke With Visible Arterial Occlusion: A Population-Based Study (Dijon Stroke Registry). | Stroke | 2020 | https://conductscience.org/library/papers/32486967 | PubMed |
| 2 | 39908448 | Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion. | N Engl J Med | 2025 | https://conductscience.org/library/papers/39908448 | PubMed |
| 3 | 39908430 | Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels. | N Engl J Med | 2025 | https://conductscience.org/library/papers/39908430 | PubMed |
| 4 | 42127389 | Endovascular Treatment of Medium-Vessel-Occlusion Strokes. | N Engl J Med | 2026 | https://conductscience.org/library/papers/42127389 | PubMed |
| 5 | 34501552 | Current Update on the Clinical Utility of MMSE and MoCA for Stroke Patients in Asia: A Systematic Review. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/34501552 | PubMed |
| 6 | 36478766 | Validation of the UK English Oxford cognitive screen-plus in sub-acute and chronic stroke survivors. | Eur Stroke J | 2022 | https://conductscience.org/library/papers/36478766 | PubMed |
| 7 | 40406877 | StrokeCog-15 Is an Efficient Neuropsychological Battery to Screen for Cognitive Impairment in Chronic Stroke. | Stroke | 2025 | https://conductscience.org/library/papers/40406877 | PubMed |
| 8 | 41614516 | The mini-Oxford cognitive screen (Mini-OCS): A very brief cognitive screen for use in chronic stroke. | Eur Stroke J | 2026 | https://conductscience.org/library/papers/41614516 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42536166
GET https://conductscience.org/api/papers/v1/42536166/authors